Stevanato Group SpA (STVN)
22.42
-0.28
(-1.21%)
USD |
NYSE |
Aug 26, 16:00
22.42
0.00 (0.00%)
After-Hours: 16:32
Stevanato Group Shareholders Equity (Quarterly) : 1.772B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.772B |
| March 31, 2026 | 1.764B |
| December 31, 2025 | 1.746B |
| September 30, 2025 | 1.689B |
| June 30, 2025 | 1.641B |
| March 31, 2025 | 1.529B |
| December 31, 2024 | 1.454B |
| September 30, 2024 | 1.476B |
| June 30, 2024 | 1.419B |
| March 31, 2024 | 1.437B |
| December 31, 2023 | 1.251B |
| Date | Value |
|---|---|
| September 30, 2023 | 1.161B |
| June 30, 2023 | 1.150B |
| March 31, 2023 | 1.120B |
| December 31, 2022 | 1.063B |
| September 30, 2022 | 943.69M |
| June 30, 2022 | 956.58M |
| March 31, 2022 | 984.62M |
| December 31, 2021 | 957.61M |
| September 30, 2021 | 917.68M |
| June 30, 2021 | 452.72M |
| March 31, 2021 | 398.51M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.122B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
| Danaher Corp. | 52.58B |
| Harvard Bioscience, Inc. | 7.418M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.994B |
| Total Liabilities (Quarterly) | 1.222B |
| Debt to Equity Ratio | 0.2858 |
| Current Ratio | 1.613 |
| Net Debt Paydown Yield | -0.33% |